Intesa Sanpaolo Wealth Management
Position in NRIX — Nurix Therapeutics, Inc.
CIK 2110902
LUXEMBOURG, N4
Position in NRIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$39,058
+$14,103 QoQ
Shares Held
1,610
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#167
of 210 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Intesa Sanpaolo Wealth Management holds $418,945 across 5 Biotechnology names. NRIX ranks #2 (9.3% of the industry book) .
All Filings in NRIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,058 | 1,610 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $24,955 | 1,610 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,541 | 1,610 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||